When did NeoGenomics report Q4 2024 earnings?

NeoGenomics (NEO) reported Q4 2024 earnings on February 18, 2025 before market open.

What were NeoGenomics's Q4 2024 revenue and EPS?

NeoGenomics reported revenue of $172.0M and eps of $0.04 for Q4 2024.

Did NeoGenomics beat estimates in Q4 2024?

Revenue missed the consensus estimate of $172.6M by $593.9K. EPS beat the consensus estimate of $0.03 by $0.01.

Where can I find NeoGenomics's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001077183-25-000028) directly on SEC EDGAR. The filing index links above go to sec.gov.

NeoGenomics NEO Q4 2024 Annual earnings

Reported February 18, 2025 · Before market open

Revenue$172.0MMiss by $593.9K

EPS$0.04Beat by $0.01

Revenue estimate$172.6M

EPS estimate$0.03

Next report

Oct 27, 2026 (in 3 months)

Revenue estimate$205.9M

EPS estimate$0.05

Financials

Q4 2024

Income statement

See full

Revenue$172.0M+10.6%

Gross profit$77.3M+14.3%

Operating income-$18.4M+0.9%

Net income-$15.3M-7.0%

EPS (diluted)-$0.12-9.1%

Balance sheet

See full

Cash & equivalents$367.0M+7.2%

Total debt$265.0M+261%

Total equity$902.3M-4.2%

Total assets$1.6B-2.6%

Cash flow

See full

Operating cash flow$9.8M—

CapEx$11.6M+64.4%

Free cash flow-$1.8M—

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$2.12B+3.8%

Enterprise value$2.01B+13.8%

P/S3.2×-0.2×

Profitability

See full

Gross margin43.9%+2.6pp

Operating margin-13.9%-2.6pp

Net margin-11.9%-2.0pp

FCF margin-5.3%—

Returns & leverage

See full

Return on equity-8.5%-0.5pp

Debt / equity0.3×+0.2×

Current ratio2×-4.2×

Segments

By product

See full

Client direct billing$190.2M+119%

Commercial insurance$26.7M+15.0%

Medicare and other government$21.7M+8.9%

Self-pay$227.0K+106%

By segment

See full

Reportable Segment$172.0M—

Versus estimates

Revenue

Q2 2026$201.7MBeat by $4.7M Q1 2026$186.7MBeat by $2.1M Q4 2025$190.2MBeat by $1.7M Q3 2025$187.8MMiss by $448.6K Q2 2025$181.3MMiss by $2.5M Q1 2025$168.0MMiss by $14.9M

Diluted EPS

Q2 2026$0.05Beat by $0.02 Q1 2026$0.01Beat by $0.00 Q4 2025$0.06Beat by $0.02 Q3 2025$0.03Beat by $0.01 Q2 2025$0.03In line Q1 2025-$0.08Miss by $0.06

Ask the moment NeoGenomics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did NeoGenomics report Q4 2024 earnings?: NeoGenomics (NEO) reported Q4 2024 earnings on February 18, 2025 before market open.
What were NeoGenomics's Q4 2024 revenue and EPS?: NeoGenomics reported revenue of $172.0M and eps of $0.04 for Q4 2024.
Did NeoGenomics beat estimates in Q4 2024?: Revenue missed the consensus estimate of $172.6M by $593.9K. EPS beat the consensus estimate of $0.03 by $0.01.
Where can I find NeoGenomics's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001077183-25-000028) directly on SEC EDGAR. The filing index links above go to sec.gov.